Data gathered: October 17
Alternative Data for Progyny
About Progyny
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.
| Price | $19.34 |
| Target Price | Sign up |
| Volume | 4,630,000 |
| Market Cap | $1.75B |
| Year Range | $19.34 - $24.27 |
| Dividend Yield | 0% |
| PE Ratio | 34.44 |
| Analyst Rating | 36% buy |
| Industry | Health Care Services |
In the news
 |
Progyny (PGNY): Exploring Valuation After Recent Momentum Shift and Investor OptimismOctober 15 - Yahoo |
Progyny CEO Named World Economic Forum Champion for Women’s HealthOctober 7 - GlobeNewswire |
|
|
Is Progyny (PGNY) Stock Undervalued Right Now?October 6 - Yahoo |
|
3 Reasons to Avoid PGNY and 1 Stock to Buy InsteadOctober 1 - Yahoo |
|
Progyny (NASDAQ:PGNY) Is Doing The Right Things To Multiply Its Share PriceSeptember 25 - Yahoo |
 |
Voya Investment Management LLC Grows Stock Holdings in Progyny, Inc. $PGNYSeptember 20 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 333M | 254M | 79M | 17M | 28M | 0.480 |
| Q1 '25 | 324M | 248M | 76M | 15M | 25M | 0.480 |
| Q4 '24 | 298M | 235M | 63M | 11M | 17M | 0.420 |
| Q3 '24 | 287M | 227M | 59M | 10M | 12M | 0.400 |
| Q2 '24 | 304M | 236M | 68M | 16M | 21M | 0.170 |
Insider Transactions View All
| Swartz Allison filed to sell 77,407 shares at $23.5. September 5 '25 |
| Swartz Allison filed to sell 79,697 shares at $23. September 2 '25 |
| GORDON KEVIN K filed to sell 12,501 shares at $22. August 13 '25 |
| Scott Cheryl filed to sell 14,112 shares at $22.1. June 12 '25 |
| Schlanger David J filed to buy 228,269 shares at $14.7. December 26 '24 |
Similar companies
Read more about Progyny (PGNY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Progyny?
The Market Cap of Progyny is $1.75B.
What is Progyny's PE Ratio?
As of today, Progyny's PE (Price to Earnings) ratio is 34.44.
What is the current stock price of Progyny?
Currently, the price of one share of Progyny stock is $19.34.
How can I analyze the PGNY stock price chart for investment decisions?
The PGNY stock price chart above provides a comprehensive visual representation of Progyny's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Progyny shares. Our platform offers an up-to-date PGNY stock price chart, along with technical data analysis and alternative data insights.
Does PGNY offer dividends to its shareholders?
As of our latest update, Progyny (PGNY) does not offer dividends to its shareholders. Investors interested in Progyny should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Progyny?
Some of the similar stocks of Progyny are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.
